Physician profile
Christopher Robert Broda
NPI 1710245378
$4,353.20
in general payments reported to CMS, 2019-2025
11 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Pediatric Cardiology provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,006 · 2020: $153 · 2021: $121 · 2022: $768 · 2023: $670 · 2024: $1,130 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,305.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,392.05 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Medtronic Vascular, INC. | $1,005.71 | 2019 | |
| Cvrx, INC. | $387.73 | 2024-2025 | Barostim Neo System |
| Edwards Lifesciences Corporation | $302.62 | 2023-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), The Edwards Sapien 3 Valve With Alterra Adaptive Prestent System |
| Actelion Pharmaceuticals US, INC. | $277.27 | 2022-2024 | Uptravi, Opsumit |
| W. L. Gore & Associates, INC. | $207.40 | 2024 | Gore Cardioform Septal Occluder |
| Abiomed | $184.97 | 2025 | |
| Medtronic, INC. | $161.23 | 2025 | Harmony |
| United Therapeutics Corporation | $152.69 | 2020 | |
| Impulse Dynamics (USA) INC. | $149.55 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $131.98 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Broda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.